Clinical trial · Interventional
Assessment Tool for Older Patients With Cancer
Determining the Utility of an Assessment Tool for Older Patients With Cancer
NCT00477958CI-TRIAL-00106629active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: A study that assesses the ability of older patients to think, learn, remember, make judgments, and carry out daily activities may help doctors plan treatment for older patients with cancer. PURPOSE: This clinical trial is studying an assessment tool in older patients with cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cognitive/Functional Effects | — | UNRESOLVED | — |
| Psychosocial Effects of Cancer and Its Treatment | — | UNRESOLVED | — |
| Unspecified Adult Solid Tumor, Protocol Specific | Adult Solid Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cognitive assessment | Procedure | — | UNRESOLVED |
| psychosocial assessment and care | Procedure | — | UNRESOLVED |
| questionnaire administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Geriatric Assessment Tool
- interventionNames
- Other: questionnaire administration
- Procedure: cognitive assessment
- Procedure: psychosocial assessment and care
Primary outcomes (1)
- measure
- Ability to predict toxicity to chemotherapy, defined as grade 3-4 toxicity, hospitalization, dose delay or reduction, or discontinuation of chemotherapy due to toxicity, as measured by a geriatric assessment tool
- timeFrame
- Prior to chemotherapy and within 30 days of completion of chemotherapy.
Secondary outcomes (1)
- measure
- Longitudinal impact of cancer and chemotherapy treatment on geriatric assessment parameters
- timeFrame
- Prior to chemotherapy and within 30 days of completion of chemotherapy.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
- Maximum age
- 120 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Pathologically confirmed cancer * Receiving chemotherapy for either adjuvant treatment or metastatic disease prior to beginning a new chemotherapy regimen PATIENT CHARACTERISTICS: * Must be able to understand English PRIOR CONCURRENT THERAPY: * See Disease Characteristics * No prior enrollment in this trial * No concurrent enrollment on a phase I clinical trial
References
Publications (0)
Data not yet available
No reference posted for this study.